Insider Transactions in Q4 2021 at Horizon Therapeutics Public LTD CO (HZNP)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
75,000
-7.19%
|
$8,100,000
$108.29 P/Share
|
|
Dec 31
2021
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+4.51%
|
$550,000
$22.14 P/Share
|
|
Dec 28
2021
|
Paul W. Hoelscher EVP, CFO |
SELL
Open market or private sale
|
Direct |
8,575
-89.1%
|
$943,250
$110.0 P/Share
|
|
Dec 28
2021
|
Paul W. Hoelscher EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,575
+47.12%
|
$128,625
$15.96 P/Share
|
|
Dec 13
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Bona fide gift
|
Indirect |
50
-0.13%
|
-
|
|
Dec 07
2021
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,525
-6.53%
|
$152,500
$100.0 P/Share
|
|
Dec 03
2021
|
Paul W. Hoelscher EVP, CFO |
SELL
Bona fide gift
|
Direct |
1,049
-50.0%
|
-
|
|
Dec 01
2021
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
SELL
Open market or private sale
|
Direct |
79,484
-68.52%
|
$8,425,304
$106.62 P/Share
|
|
Dec 01
2021
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
79,484
+40.66%
|
$1,748,648
$22.14 P/Share
|
|
Nov 30
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-3.1%
|
$5,100,000
$102.55 P/Share
|
|
Nov 08
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Bona fide gift
|
Indirect |
10,729
+22.1%
|
-
|
|
Nov 08
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
10,729
-54.07%
|
-
|
|
Nov 04
2021
|
Barry Moze EVP, Chief Admin. Officer |
SELL
Open market or private sale
|
Direct |
75,743
-10.81%
|
$8,483,216
$112.99 P/Share
|
|
Nov 04
2021
|
Barry Moze EVP, Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,743
+12.18%
|
$1,211,888
$16.14 P/Share
|
|
Nov 04
2021
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
30,168
-12.72%
|
$3,408,984
$113.02 P/Share
|
|
Nov 04
2021
|
Andy Pasternak EVP, Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,251
+30.29%
|
$674,279
$29.52 P/Share
|
|
Nov 01
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.09%
|
$2,950,000
$118.8 P/Share
|
|
Nov 01
2021
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,503
-15.38%
|
$649,354
$118.29 P/Share
|
|
Nov 01
2021
|
Andy Pasternak EVP, Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,421
+25.77%
|
-
|
|
Oct 27
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,729
+35.09%
|
$75,103
$7.61 P/Share
|
|
Oct 26
2021
|
Timothy P Walbert Chairman, President and CEO |
BUY
Bona fide gift
|
Indirect |
100,300
+50.0%
|
-
|
|
Oct 26
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Bona fide gift
|
Indirect |
100,300
-76.28%
|
-
|